NICE at 10 years: New challenges ahead

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 9, Issue 2, 2009, Pages 151-156

  Littlejohns, Peter ^a,b  

^a NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cost effectiveness; National Health Service; NICE; Public health

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG APPROVAL; DRUG COST; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH PROMOTION; MEDICAL RESEARCH; NATIONAL HEALTH SERVICE; COST BENEFIT ANALYSIS; EVIDENCE BASED MEDICINE; GOVERNMENT; HEALTH CARE PLANNING; HISTORY; LEGAL ASPECT; PRACTICE GUIDELINE; PUBLIC HEALTH;

COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; GOVERNMENT AGENCIES; GUIDELINES AS TOPIC; HEALTH PLANNING GUIDELINES; HEALTH PROMOTION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; PUBLIC HEALTH; STATE MEDICINE;

EID: 68349138402     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.09.13     Document Type: Article

References (17)

1. Littlejohns P, Barnett D, Longson C. The cancer technology appraisal program of the UK's National Institute for Clinical Excellence. Lancet Oncol. 14, 242-250 (2003).
2. Littlejohns P, Garner S, Doyle N, Macbeth F, Barnett D, Longson C. 10 years of NICE: still growing and still controversial. Lancet Oncol. 10, 417-424 (2009).
3. Littlejohns P Kelly M. The changing face of NICE: the same but different. Lancet 366, 791-794 (2005).
4. Wanless D. Securing Good Health for the Whole Population: Final Report. HM Treasury, London, UK (2004).
5. Department of Health. Choosing Health: Making Healthy Choices Easier. The Stationary Office, London, UK (2004).
6. Darzi AW. High Quality Care for All. NHS Next Stage Review Final Report (Cm 7432). The Stationary Office, London, UK (2008).
7. Office of Fair Trading. Pharmaceutical Price Regulation Scheme. An OFT Market Study. Office of Fair Trading, London, UK (2007).
8. Department of Health/Association of the British Pharmaceutical Industry. Pharmaceutical Price Regulation Scheme. Department of Health, London, UK (2008).
9. Richards M. Improving Access to Medicines for NHS Patients. Department of Health, London, UK (2008).
10. Cooksey D. A Review of UK Health Research Funding. The Stationery Office, London, UK (2006).
11. Chalkidou K, Lord J, Fischer A, Littlejohns P. Evidence based decision making in healthcare: when should we wait for more information? Health Aff. 27(6), 1642-1653 (2008).
12. Chalkidou K, Walley T, Littlejohns P, Culyer A. Evidence-informed evidence-making. J. Health Serv. Res. Policy 13, 167-173 (2008).
13. Rawlins M. De testimonio: on the evidence for decisions about the use of therapeutic interventions. Lancet 372(9656), 2152-2161 (2008).
14. Department of Health. Standards for Better Health. Department of Health, London, UK (2004).
15. Godlee F. NICE at 10 (Editor's Choice). BMJ 338, B344 (2009).
16. Pearson S, Littlejohns P. Reallocating resources: how should the National Institute for Health and Clinical Excellence guide disinvestment in the NHS. J. Health Serv. Res. Policy 12, 160-165 (2007).
17. Hawkes N. NICE goes global. BMJ 338, B103 (2009).